The Community Oncology Alliance (COA) 2022 Community Oncology Conference celebrates community oncology’s hard work treating patients with cancer during a public health emergency. The Conference brings cutting edge information straight to you, and renowned experts from across the industry are waiting to share their advice. Community oncology is a shining beacon of hope for patients with cancer – it’s time to take the next step forward at the 2022 COA Conference!
The Community Oncology Alliance (COA) 2022 Community Oncology Conference celebrates community oncology’s hard work treating patients with cancer during a public health emergency. The Conference brings cutting edge information straight to you, and renowned experts from across the industry are waiting to share their advice. Community oncology is a shining beacon of hope for patients with cancer – it’s time to take the next step forward at the 2022 Community Oncology Conference!
World Class Faculty & Speakers
The annual Community Oncology Conference continues to be developed by community oncology providers, administrators, staff, and patients to address their needs in the real world. Session content comes from careful consideration by COA’s leaders, members, and networks.
The 2022 Community Oncology Conference Co-Chairs are:
- Stephen “Fred” Divers, MD, Genesis Cancer & Blood Institute & American Oncology Network, LLC (AON), Hot Springs, AR
- Debra Patt, MD, PhD, MBA, Texas Oncology & US Oncology, Austin, TX
- Jeffrey Patton, MD, Tennessee Oncology & OneOncology, Nashville, TN
- Alti Rahman, MHA, MBA, CSSBB, Oncology Consultants, Houston, TX
- Barry Russo, The Center for Cancer & Blood Disorders & OneOncology, Fort Worth, TX
- Jeff Vacirca, MD, FACP, New York Cancer & Blood Specialists & OneOncology, Long Island, NY
Fantastic Keynote Speakers
This year, the Community Oncology Conference features a double-header of fantastic keynote speakers that will be guaranteed to inform and entertain.
Trey Mancini
On Thursday, we will hear from Trey Mancini, Baltimore Orioles’ first baseman and colon cancer survivor. He will speak about the lifesaving difference community oncology made for him.
Adam Fein
On Friday, we will hear from Adam Fein, one of the country’s foremost experts on pharmaceutical economics and channel strategy. He writes the popular and influential Drug Channels website.
Attend In-Person or Virtually!
Attendees and Exhibitors were afforded the option to attend in-person or virtually from March 17-18, 2022. In-person was held at the Gaylord Palms Hotel outside Orlando and virtual from the comfort of your home or office while watching presenters from across the country share valuable content and lessons with the broad oncology community.
THANK YOU
Exhibitors
Executive Platinum
The AmerisourceBergen (AB) Specialty GPOs ION Oncology Network
The AmerisourceBergen (AB) Specialty GPOs ION Oncology Network is the largest oncology-specific GPO and preferred strategic partner for community oncology practices nationwide.
With over 20 years of experience, you can rely on us for more than GPO contracts. In addition to giving you access to the most advanced therapies at competitive rates, our experts take pride in helping member practices tap the potential within their business. Whether you’re interested in uncovering new clinical and operational efficiencies, opening new lines of revenue, or need support navigating the transition to value-based reimbursement—AB Specialty GPOs will be there to help you, every step of the way.
In 1998, Oncology Supply became the exclusive distributor for the ION Oncology Network. For more than 40 years, they have stood side by side with community oncology practices across the United States. With access to the entire AmerisourceBergen network, they improve product access, increase supply chain efficiency and work diligently to support practices in enhancing patient care.
Follow ION
Follow OS
Astellas
Astellas Pharma US, Inc. is a U.S. affiliate of Tokyo-based Astellas Pharma Inc., a pharmaceutical conducting business in more than 70 countries around the world. Astellas stands on the forefront of healthcare change to turn innovative science into value for patients. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the U.S. and around the world. For more information on Astellas, please visit: https://www.astellas.com/us
Follow Us
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. For more information, please visit www.astrazeneca-us.com
Follow Us
Bristol Myers Squibb
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.
CardinalHealth
Cardinal Health Specialty Solutions empowers community oncology practices to navigate the future of oncology care. Working in close collaboration with each practice, we develop and implement a clear roadmap to meet pressing challenges in a new era. With expert insights, responsive tools and committed support, we enable our customers to deliver high-quality, cost-efficient care and future-proof their practices.
Follow Us
Daiichi-Sankyo
Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an “Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.” For more information, please visit www.daiichisankyo.com.
Daiichi Sankyo, Inc., headquartered in Basking Ridge, New Jersey, is a member of the Daiichi Sankyo Group. To learn more about Daiichi Sankyo, Inc., please visit www.daiichisankyo.us
Flatiron Health®
Flatiron Health® is a healthtech company that marries clinical and data science to improve outcomes for patients today and tomorrow. We translate patient experiences into real-world evidence to advance research and inform policy. Flatiron HC isn’t just a leading EHR. It’s the platform for a better patient experience, a healthier practice and smarter research. We help doctors provide better care for their patients.
Follow Us
Foundation Medicine
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient’s unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. For more information, visit FoundationMedicine.com.
Genentech
For more than 40 years, we’ve been following the science, seeking solutions to unmet medical needs. As a proud member of the Roche Group, we make medicines to treat patients with serious medical conditions.
We are headquartered in South San Francisco, California.
Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte. For more information on Jakafi® (ruxolitinib), visit hcp.jakafi.com. For more information on MONJUVI® (tafasitamab-cxix), visit monjuvihcp.com. For more information on Pemazyre® (pemigatinib), visit hcp.pemazyre.com.
Follow Us
Janssen
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart.
Follow Us
Merck
McKesson
McKesson helps specialty providers run successful businesses by clearing the path for them to focus on patient care. We do this with solutions that make practice management more manageable and our “all in” approach to advocacy, consultancy, and collaboration. We invite you to discover and explore the McKesson difference.
Through The US Oncology Network, we give physician-owned specialty practices hands-on practice management support with the infrastructure, expertise and strength to succeed in today’s competitive healthcare environment.
Follow McKesson
Follow US Oncology Network
Pharmacyclics
For more information about Pharmacyclics LLC, an AbbVie Company, please visit pharmacyclics.com.
Follow Us
Gold
Adaptive Biotechnologies
Adaptive Biotechnologies is a commercial-stage biotech company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. Adaptive’s goal is to develop and commercialize immune-driven diagnostics and therapeutics tailored to each individual patient.
Follow Us
BeiGene
BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our 5,400+ employees around the world are committed to expediting the development of a diverse pipeline of novel therapeutics.
Follow Us
Eisai Co., Ltd.
As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., our passionate commitment to patient care is the driving force behind our efforts to help address unmet medical needs. We are a fully integrated pharmaceutical business with discovery, clinical, and marketing capabilities. Our key areas of focus include oncology and neurology (dementia-related diseases and neurodegenerative diseases). To learn more about Eisai Inc., please visit us at www.eisai.com/US and follow us on Twitter and LinkedIn.
Follow Us
EMD Serono
At EMD Serono, science is at the heart of everything we do. It drives the discoveries we make and the technologies we create. Our employees are dedicated to making a positive difference in the lives of patients and their loved ones. EMD Serono is the healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada.
Fresenius Kabi
Fresenius Kabi is a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, and we supply the US oncology market with one of the largest injectable oncology portfolios in the industry. We’re now committed to launching a range of biosimilars in the US with our BioSpecialized approach to health care. From the collaborative way we work with health care professionals to how we manufacture and deliver our products, we are committed to going beyond medicines to support patient care.
Follow Us
House Rx
House Rx is a technology-enabled service company focused on helping specialty practices dispense medications directly to their patients and avoid the challenges of using outside specialty pharmacies. We support clinics through the entire dispensing process by equipping them with pharmacist expertise and modern technology. Specialized pharmacy care coordinators and pharmacists are central to our service to ensure world-class patient care and experience. By partnering with practices, we’re able to improve patient outcomes, lower the cost of care, and create a better experience for physicians and care teams.
Ipsen Biopharmaceuticals, Inc
Ipsen Biopharmaceuticals, Inc. is a US affiliate of Ipsen SA, a global biotech company. At Ipsen Biopharmaceuticals, we are focused on developing and providing access to therapies for patients who suffer from extremely difficult-to-treat diseases. For more information on Ipsen in North America, please visit www.ipsenus.com. To report adverse events, call 1-855-463-5127.
Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to developing medicines for people with serious diseases — often with limited or no options.
MorphoSys
Founded in 1992 in Germany, MorphoSys is dedicated to making exceptional, innovative biopharmaceuticals to help improve lives of patients suffering from serious diseases. Based on its leading expertise in antibody, protein and peptide technologies, MorphoSys has developed and contributed to the development of more than 100 product candidates, 27 of which are currently in clinical development.
MorphoSys is headquartered in Planegg, Germany. In 2019, the US head office was established in Boston.
As of July 15, 2021, Constellation Pharmaceuticals is a MorphoSys company.
Together, we are committed to delivering breakthrough therapies that bring hope to life.
Follow Us
Myriad
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad discovers and commercializes genetic tests that determine the risk of developing disease, assess the risk of disease progression, and guide treatment decisions across medical specialties where critical genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit the company’s website: www.myriad-oncology.com
Follow Us
OneOncology
OneOncology was founded by community oncologists, for community oncologists, with the mission of improving the lives of everyone living with cancer.
We are a platform of the nation’s leading independent oncology practices consisting of 726 providers, practicing at 260+ sites of care and serving over 421,000 patients per year. We are bringing the latest cancer research and treatment options to patients close to home. OneOncology invests in practices to help them grow within their local markets, diversify across multiple specialties, apply data insights and leverage technology to strengthen performance.
Join the partnership.
Drive the future.
Seagen
Seagen Inc. is a global biotechnology company that discovers, develops, and commercializes medicines for cancer. The company has a pipeline of therapies at various stages of preclinical testing, clinical testing, and development. We are leveraging our expertise in antibodies to build a portfolio of proprietary antibody-drug conjugates and immuno-oncology agents in clinical trials for hematologic malignancies and solid tumors. For more information, visit www.seagen.com.
Follow Us
Silver
AbbVie
At AbbVie, we are committed to transforming standards of care for blood cancers while advancing a dynamic pipeline of investigational therapies across many cancer types. Our dedicated team joins forces with innovative partners to accelerate the delivery of potentially breakthrough medicines for patients. We are evaluating more than 20 investigational medicines in over 300 clinical trials across some of the most debilitating cancers. For more details, please visit http://www.abbvie.com/oncology.
Follow Us
American Oncology Network, LLC (AON)
American Oncology Network, LLC (AON) is an alliance of physicians and veteran healthcare leaders dedicated to ensuring the long-term success and viability of oncology diagnosis and treatment in community-based settings. It is the fastest growing network of community oncology practices delivering local access to exceptional cancer care. Launched in 2018 by the physicians and administrators from the nations’ largest independent community oncology practice, AON’s network has expanded in three years to include more than 170 providers in 16 states.
AON serves its expanding network of partner practices by providing over 36 years of proven practice management expertise, dedicated end-to-end administrative support, and access to an extensive array of centralized ancillary support services that are challenging to maintain independently, yet so critical to the delivery of true value-based cancer care. Through access to centralized services such as patient financial counseling, revenue cycle management, drug purchasing, payer contracting and IT, as well as enhanced services such as pathology and an oral-oncolytic pharmacy, AON practices have realized significant results in increased productivity and improved operations while providing high quality patient care.
Follow Us
Exact Sciences
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smart solutions providing the clarity to take life-changing action, earlier. Building on the success of the Cologuard®, Oncotype DX®, and Oncotype MAP™ tests, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. For more information, visit www.exactsciences.com or www.OncotypeIQ.com
Follow Us
G1 Therapeutics
G1 Therapeutics, Inc., is a commercial-stage biopharmaceutical company focused on the discovery, development, and delivery of next-generation therapies. The company’s first commercially available product, COSELA™ (trilaciclib), was recently approved by the US Food and Drug Administration.
G1 Therapeutics, Inc., is based in Research Triangle Park, North Carolina. For additional information, please visit www.g1therapeutics.com.
G1 Therapeutics™ and the G1 Therapeutics logo, COSELA™ and the COSELA logo are trademarks of G1 Therapeutics, Inc.
©2021 G1 Therapeutics, Inc. All rights reserved. US-2100170 07/2021
GSK
GSK is focused on maximizing patient survival through transformational medicines. GSK’s oncology pipeline is focused on immuno-oncology, oncology cell therapy, tumor cell targeting and synthetic lethality. Our goal is to achieve a sustainable flow of new treatments based on a diversified portfolio of investigational medicines utilizing modalities such as small molecules, antibodies, antibody drug conjugates and cells, either alone or in combination.
Follow Us
Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved milestones in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to developing and advancing innovative medicines to prevent and treat life-threatening diseases. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.
ã 2022 Gilead Sciences, Inc. All rights reserved.
Follow Us
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of novel first-in-class drugs for the treatment of cancer and other diseases. Karyopharm’s Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1. The company was founded in 2008 with a vision of pioneering a potentially new approach to treating patients with certain blood cancers [or solid tumor malignancies]. The company markets a drug for multiple myeloma and diffuse large B Cell lymphoma.
Kite Pharma
For the past three decades, members of our team have been at the forefront of cancer immunotherapy. Today, we are a leader in engineered T cell therapy, transforming cancer treatment with what is potentially the biggest breakthrough since the introduction of combination chemotherapy more than 60 years ago.
Follow Us
LeanTaaS
LeanTaaS: LeanTaaS develops software that increases patient access to medical care by optimizing how health systems use expensive, constrained resources like infusion chairs, operating rooms, and inpatient beds.
iQueue for Infusion Centers: Over 485 infusion sites with over 10,000 chairs, including 80% of the National Comprehensive Cancer Network (NCCN) and more than 50% of National Cancer Institute (NCI) hospitals, rely on iQueue for Infusion Centers to increase access, decrease patient wait time, and lower healthcare delivery costs.
Novartis
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 109,000 people of more than 145 nationalities work at Novartis around the world. Find out more at www.novartis.com
Pfizer Oncology
At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications. Going forward, we are focused on delivering a next wave of breakthroughs in breast cancer, genitourinary cancer, hematology and precision medicine.
Follow Us
Sanofi
Sanofi is an innovative global healthcare company. We are working to advance transformative therapies to help people with cancer. Our current focus is on multiple myeloma and other blood cancers, skin, prostate, lung, and breast cancers. We take bold steps every day to advance our pipeline and work to find solutions that help address critical gaps in care across a variety of difficult-to-treat cancers.
SCiO
SCIO Management Solutions is a revenue cycle management and consulting firm focused on cancer disease related specialties with extensive knowledge in medical and radiation oncology, diagnostics, and various surgical specialties. We understand the complexity of buy-and-bill medical specialties, value based care models, and provide expertise to improve revenue recovery.
SCIO’s Consulting and Auditing Services not only identify the gaps in a practice’s revenue cycle, but SCIO will correct the errors and refile the corrected claims on behalf of your practice. Our Revenue Recovery Audits are contingency based, so there are no upfront fees and we only collect a percentage of the recovered revenue recognized in the audit that your practice wasn’t aware was missing.
Takeda Oncology
At Takeda Oncology, we aspire to cure cancer, with inspiration from patients and innovation from everywhere. We ensure a tight connection from research to development to commercialization too rapidly meet the needs of the cancer community, optimizing our ability to bring transformative medicines to patients. Our demonstrated leadership in the treatment of hematologic cancers and solid tumors combined with cutting-edge science through multiple platforms, partnerships and therapeutic approaches enable us to bring novel medicines to patients worldwide.
For more information, visit www.takedaoncology.com.
Follow Us
The Oncology Institute
Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting.
TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.5 million patients including clinical trials, stem cell transplants, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations.
With 80+ employed clinicians and more than 600 teammates in 50 clinic locations and growing, TOI is changing oncology for the better.
Follow Us
Viatris
Viatris empowers people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to improve patient health.
Link to Our Story: https://www.viatris.com/en/about-us/our-story
Zyno Solutions
Zyno Solutions provides cost-effective IV infusion solutions and is dedicated to delivering intelligent infusion systems that provide the highest quality of care and patient safety. We offer large volume infusion pumps, ambulatory infusion pumps, integrated wireless infusion systems and IV accessories. We provide these devices and systems for ambulatory infusion suites, oncology infusion suites, long-term care pharmacies, specialty pharmacies and home care providers.
Follow US
THANK YOU
Sponsors
Amgen
At Amgen, we are committed to the relentless pursuit of breakthroughs for cancer patients and their families. Visit AmgenOncology.com to learn more.
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. For more information, please visit www.astrazeneca-us.com
Follow Us
BeiGene
BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our 5,400+ employees around the world are committed to expediting the development of a diverse pipeline of novel therapeutics.
Follow Us
CardinalHealth
Cardinal Health Specialty Solutions empowers community oncology practices to navigate the future of oncology care. Working in close collaboration with each practice, we develop and implement a clear roadmap to meet pressing challenges in a new era. With expert insights, responsive tools and committed support, we enable our customers to deliver high-quality, cost-efficient care and future-proof their practices.
Follow Us
Deciphera
We are a commercial-stage biopharmaceutical company on a mission to deliver transformational medicines to patients. Headquartered in Waltham, MA with research facilities in Lawrence, KS, we develop innovative science to provide hope to people living with cancer. Fueled by our proprietary drug discovery platform, Deciphera’s mission is to discover, develop, and deliver important new medicines to patients for the treatment of cancer. We aim to provide novel treatments for patients through inhibition of protein kinases. We are focused on discovering, developing, and delivering important new medicines to patients for the treatment of cancer. Our commitment to patients is at the center of everything we do. We are dedicated. We are focused. We are motivated.
Patient access url: https://www.decipheraaccesspoint.com/
Follow Us
Integra Connect
Integra Connect is driven to make specialty care practices clinically and financially successful through value-based, precision medicine.
By focusing on both clinical and business outcomes, Integra Connect enables customers across the care continuum — including providers, payers, and life sciences companies — to harness value-based, precision medicine to improve their decision-making, and make a difference in patients’ lives.
Integra Connect solutions are helping to accelerate adoption of value-based, precision medicine through:
- Precision Medicine Solutions for Providers, which help users deliver high quality patient care and experiences, while managing costs.
- Revenue Cycle Management Solutions that help practices boost collections, accelerate the billing process, and find hidden growth potential.
- The Integra Connect Platform, which enables customers to advance research, improve drug development and maximize revenue.
- Population Health Solutions that support provider efforts to identify at-risk patients and populations for proactive intervention, optimize costs and quality performance, and excel under value-based payment models.
- The IntegraCloud EHR, which helps users understand the patient journey, improve work efficiency, integrate care and information flows, and easily analyze and report performance.
- Precision Medicine Solutions for Life Sciences that enable customers to identify opportunities for clinical research and drug development, support pipeline, and launch medicines for the benefit of patients.
Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to developing medicines for people with serious diseases — often with limited or no options.
Lilly Oncology
For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. To learn more about Lilly’s commitment to people with cancer, please visit www.LillyOncology.com.
McKesson
McKesson helps specialty providers run successful businesses by clearing the path for them to focus on patient care. We do this with solutions that make practice management more manageable and our “all in” approach to advocacy, consultancy, and collaboration. We invite you to discover and explore the McKesson difference.
Through The US Oncology Network, we give physician-owned specialty practices hands-on practice management support with the infrastructure, expertise and strength to succeed in today’s competitive healthcare environment.
Follow McKesson
Follow US Oncology Network
NeoGenomics
NeoGenomics is a premier oncology diagnostics company with a comprehensive oncology menu that includes all testing modalities for solid tumor and hematologic malignancies to help solve the diagnostic, prognostic and predictive questions in cancer care.
Comprehensive diagnostic, prognostic and predictive testing with more than 600 tests covering solid tumor and hematologic malignancies. We offer 26 cancer-specific, multi-methodology assays in targeted and broad-based profiles designed to detect genomic alterations in clinically significant driver genes centered on NGS, FISH, and IHC.
NeoGenomics’ NGS menu includes 17 targeted RNA fusion profiles that detects common and novel fusions partners. We have an NGS assay for pan-cancer that provides single order testing solution for solid tumors and includes 44 genes involved in solid tumor development and progression, and an NGS-based liquid biopsy test that detects actionable genes relevant to the treatment and management of advanced non-small cell lung cancer.
NeoGenomics’ flexible test menu meets the clinical demands for every patient. It’s all part of our mission to save lives through improved patient care.
Follow Us
OneOncology
OneOncology was founded by community oncologists, for community oncologists, with the mission of improving the lives of everyone living with cancer.
We are a platform of the nation’s leading independent oncology practices consisting of 726 providers, practicing at 260+ sites of care and serving over 421,000 patients per year. We are bringing the latest cancer research and treatment options to patients close to home. OneOncology invests in practices to help them grow within their local markets, diversify across multiple specialties, apply data insights and leverage technology to strengthen performance.
Join the partnership.
Drive the future.
Pfizer Oncology
At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 24 approved innovative cancer medicines and biosimilars across more than 30 indications. Going forward, we are focused on delivering a next wave of breakthroughs in breast cancer, genitourinary cancer, hematology and precision medicine.
Follow Us
rxvantage
RxVantage transforms how medical practices engage with life science resources and expertise. Through automation, customization, and technology, RxVantage gives practices smarter connections to innovative solutions that are powering patient care. Our apps intelligently connect healthcare providers with the precise life science resources that they need, when they need them. As a result, medical practices stay on the cutting edge of patient care without disrupting workflows.
Sanofi
Teva Pharmaceuticals
Teva Pharmaceuticals has been developing and producing medicines for more than a century. We are a global leader in generic and specialty medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products.